1. Editorial

   • E. P. Allhoff

   EditorialNotes Pages: 167 - 167

2. Renal cell carcinoma: physiology, diagnosis, and therapy

   • A. S. Abi-Aad
   • A. Belldegrun
   • J. B. deKernion

   OriginalPaper Pages: 168 - 172

3. Surgical treatment of renal cell carcinoma with extension into the vena cava

   • G. D. Steinberg
   • B. A. Reitz
   • F. F. Marshall

   OriginalPaper Pages: 173 - 177

4. Parenchyma-sparing surgery for renal tumors

   • F. Steinbach
   • M. Stöckle
   • R. Hohenfellner

   OriginalPaper Pages: 178 - 183

5. Complete spontaneous regression in metastatic renal cell carcinoma — an update and review

   • W. de Riese
   • E. Allhoff
   • U. Jonas

   OriginalPaper Pages: 184 - 191

6. Use of animal models in diagnosis and treatment of renal cell carcinoma

   • R. J. A. van Moorselaar
   • J. A. Schalken
   • F. M. J. Debruyne

   OriginalPaper Pages: 192 - 197

7. Monoclonal antibodies and renal cell carcinoma — current possibilities and future options

   • B. J. Schmitz-Dräger
   • T. Ebert
   • K. Decken

   OriginalPaper Pages: 198 - 203

8. Current strategies for immunotherapy of renal cell carcinoma

   • R. Heicappell
   • R. Ackermann

   OriginalPaper Pages: 204 - 209

9. Long-term results in patients with metastatic renal cell carcinoma treated with interferon with or without vinblastine

   • S. D. Fosså
   • A. E. Stenwig
   • H. H. Lien

   OriginalPaper Pages: 210 - 214

10. Interleukin-2 and interferon-alpha_2b as a daily alternating schedule in advanced renal cell cancer

    • L. Bergmann
    • E. Weidmann
    • P. S. Mitrou

    OriginalPaper Pages: 215 - 218

11. Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α

    • H. Kirchner
    • W. de Riese
    • J. Atzpodien

    OriginalPaper Pages: 219 - 222

12. Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon α_2b

    • S. Pomer
    • R. Thiele
    • G. Staehler

    OriginalPaper Pages: 223 - 227

13. Current clinical relevance of immunotherapy in metastatic renal cell cancer

    • E. P. Allhoff
    • S. Liedke
    • U. Jonas

    OriginalPaper Pages: 228 - 231

14. Adjuvant therapy in renal cancer

    • M. Goepel
    • H. Rübben

    OriginalPaper Pages: 232 - 236

15. Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivo

    • C. G. Stief
    • F. Holmquist
    • U. Jonas

    Free Paper Pages: 237 - 239

16. Cancer of prostate with osseous metastases prolonged pain relief with very high-dose epidural morphine

    • A. Stav
    • L. Ovadia
    • A. Sternberg

    Free Paper Pages: 240 - 242